Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
BIOLEADERS CORPORATION |
End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 2,100.00 KRW | -3.00% | -14.11% | -41.18% | |
| Sep. 18 | Bioleaders Corporation(KOSDAQ:A142760) dropped from S&P Global BMI Index | CI |
| May. 12 | Bioleaders Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| Sales 2022 | 100 B 77.32 M | Sales 2023 * | - | Capitalization | 112 B 86.45 M |
|---|---|---|---|---|---|
| Net income 2022 | -23.14 B -17.82 M | Net income 2023 * | - | EV / Sales 2022 | 1,32x |
| Net Debt 2022 | 20.64 B 15.89 M | Net cash position 2023 * | - 0 | EV / Sales 2023 * | - |
| P/E ratio 2022 | -4,45x | P/E ratio 2023 * | Employees | - | |
| Yield 2022 | - | Yield 2023 * |
-
| Free-Float | 86.94% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.00% | ||
| 1 week | -17.65% | ||
| Current month | +33.16% | ||
| 1 month | +30.43% | ||
| 3 months | -30.69% | ||
| 6 months | -45.74% | ||
| Current year | -41.18% |
1 week
2 075.00
2 445.00
1 month
1 560.002 985.00
Current year
1 500.005 200.00
1 year
1 500.005 200.00
3 years
1 500.0018 450.00
5 years
1 500.0018 450.00
10 years
1 500.0030 600.00
| Managers | Title | Age | Since |
|---|---|---|---|
Young-Chul Park
CEO | Chief Executive Officer | 55 | - |
Chun-Soo Lee
PSD | President | 72 | - |
Byung-Gyun Ham
AUD | Comptroller/Controller/Auditor | 55 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jun-Woo Park
BRD | Director/Board Member | 47 | - |
Chun-Soo Lee
PSD | President | 72 | - |
Young-Chul Park
CEO | Chief Executive Officer | 55 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-11-30 | 2,100.00 | -3.00% | 386,418 |
| 23-11-29 | 2,165.00 | -2.91% | 360,628 |
| 23-11-28 | 2,230.00 | -2.83% | 493,750 |
| 23-11-27 | 2,295.00 | -3.97% | 496,771 |
| 23-11-24 | 2,390.00 | -2.25% | 635,956 |
End-of-day quote Korea Stock Exchange, November 29, 2023
More quotes
BL Corp, formerly Bioleaders Corporation, is a Korea-based company primarily engaged in the research and development of biotechnology and biopharmaceuticals. The Company is engaged in the manufacture and sale of health functional foods and functional cosmetics. In addition, the Company is engaged in the distribution of pharmaceuticals and medical supplies. The Company is engaged in the distribution of Glu 100 Tablets, CellribonQ, and GentaQ and other medicine to general hospitals and pharmacies.
Sector
Pharmaceuticals
Calendar
2024-03-31
- Q4 2023 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -41.18% | 54 M $ | |
| +61.56% | 532 B $ | |
| +48.29% | 452 B $ | |
| -12.45% | 366 B $ | |
| -7.63% | 256 B $ | |
| -11.89% | 245 B $ | |
| -18.74% | 217 B $ | |
| +1.83% | 199 B $ | |
| -9.73% | 197 B $ | |
| -40.53% | 170 B $ |
